BRIACELL THERAPEUTICS CORP's ticker is BCTX and the CUSIP is 10778Y302. A total of 26 filers reported holding BRIACELL THERAPEUTICS CORP in Q1 2022. The put-call ratio across all filers is 0.14 and the average weighting 0.4%.
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Lynwood Capital Management Inc. | 750,000 | $7,605,000 | 8.16% |
| K.J. Harrison & Partners Inc | 1,351,782 | $13,749,000 | 2.21% |
| Redmond Asset Management, LLC | 137,942 | $1,399,000 | 0.42% |
| SABBY MANAGEMENT, LLC | 29,962 | $304,000 | 0.04% |
| Concord Wealth Partners | 16,775 | $170,000 | 0.04% |
| Leonard Green & Partners, L.P. | 500,000 | $5,070,000 | 0.04% |
| Summit Trail Advisors, LLC | 35,000 | $355,000 | 0.03% |
| WASATCH ADVISORS LP | 244,691 | $2,481,000 | 0.01% |
| Apollon Wealth Management, LLC | 13,900 | $141,000 | 0.01% |
| NATIONAL BANK OF CANADA /FI/ | 156,900 | $1,591,000 | 0.01% |